Tianzhen Xu

2.4k total citations · 2 hit papers
18 papers, 1.9k citations indexed

About

Tianzhen Xu is a scholar working on Pathology and Forensic Medicine, Pharmacology and Rehabilitation. According to data from OpenAlex, Tianzhen Xu has authored 18 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 6 papers in Pharmacology and 4 papers in Rehabilitation. Recurrent topics in Tianzhen Xu's work include Spine and Intervertebral Disc Pathology (7 papers), Wound Healing and Treatments (4 papers) and Musculoskeletal pain and rehabilitation (4 papers). Tianzhen Xu is often cited by papers focused on Spine and Intervertebral Disc Pathology (7 papers), Wound Healing and Treatments (4 papers) and Musculoskeletal pain and rehabilitation (4 papers). Tianzhen Xu collaborates with scholars based in China and United States. Tianzhen Xu's co-authors include Weiyang Gao, Cong Mao, Bo Lei, Cai Lin, Chenggui Wang, Min Wang, Xingxing Zhang, Huazi Xu, Yi Guo and Yuewei Xi and has published in prestigious journals such as ACS Nano, Free Radical Biology and Medicine and Cell Death and Disease.

In The Last Decade

Tianzhen Xu

17 papers receiving 1.9k citations

Hit Papers

Engineering Bioactive Sel... 2018 2026 2020 2023 2018 2019 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tianzhen Xu China 13 781 637 505 340 284 18 1.9k
Yiqiang Hu China 29 926 1.2× 1.2k 1.9× 546 1.1× 711 2.1× 222 0.8× 55 3.0k
Shaohai Qi China 27 907 1.2× 519 0.8× 413 0.8× 230 0.7× 77 0.3× 87 2.0k
Liangcong Hu China 26 716 0.9× 922 1.4× 418 0.8× 364 1.1× 52 0.2× 48 2.3k
Yongjun Zheng China 20 566 0.7× 332 0.5× 268 0.5× 180 0.5× 61 0.2× 56 1.4k
Arman Saparov Kazakhstan 24 601 0.8× 690 1.1× 672 1.3× 414 1.2× 55 0.2× 42 2.6k
Chenchen Yan China 24 693 0.9× 944 1.5× 373 0.7× 248 0.7× 42 0.1× 41 2.0k
Huang Fang China 21 275 0.4× 864 1.4× 120 0.2× 194 0.6× 360 1.3× 75 2.2k
Carlos Zgheib United States 22 905 1.2× 474 0.7× 445 0.9× 250 0.7× 38 0.1× 60 1.9k
Ye Wu China 20 557 0.7× 175 0.3× 552 1.1× 398 1.2× 300 1.1× 58 1.7k
Xingxing Zhang China 14 903 1.2× 634 1.0× 569 1.1× 408 1.2× 39 0.1× 34 1.9k

Countries citing papers authored by Tianzhen Xu

Since Specialization
Citations

This map shows the geographic impact of Tianzhen Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianzhen Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianzhen Xu more than expected).

Fields of papers citing papers by Tianzhen Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianzhen Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianzhen Xu. The network helps show where Tianzhen Xu may publish in the future.

Co-authorship network of co-authors of Tianzhen Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Tianzhen Xu. A scholar is included among the top collaborators of Tianzhen Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianzhen Xu. Tianzhen Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Tang, Chengxuan, et al.. (2023). Sitagliptin attenuates neuronal apoptosis via inhibiting the endoplasmic reticulum stress after acute spinal cord injury. Human & Experimental Toxicology. 42. 3530187001–3530187001. 1 indexed citations
3.
Xu, Tianzhen, et al.. (2021). Critical roles of sphingosine kinase 1 in the regulation of neuroinflammation and neuronal injury after spinal cord injury. Journal of Neuroinflammation. 18(1). 50–50. 34 indexed citations
4.
Zhang, Zengjie, Tianzhen Xu, Jiaoxiang Chen, et al.. (2021). Correction: Parkin-mediated mitophagy as a potential therapeutic target for intervertebral disc degeneration. Cell Death and Disease. 12(10). 915–915. 1 indexed citations
5.
Li, Yannan, Tianzhen Xu, Zhuolong Tu, et al.. (2020). Bioactive antibacterial silica-based nanocomposites hydrogel scaffolds with high angiogenesis for promoting diabetic wound healing and skin repair. Theranostics. 10(11). 4929–4943. 194 indexed citations
6.
Lin, Jialiang, Xuan-Qi Zheng, Yuhao Wu, et al.. (2020). Urolithin A-induced mitophagy suppresses apoptosis and attenuates intervertebral disc degeneration via the AMPK signaling pathway. Free Radical Biology and Medicine. 150. 109–119. 104 indexed citations
7.
Shao, Zhenxuan, Libin Ni, Sunli Hu, et al.. (2020). RNA‐binding protein HuR suppresses senescence through Atg7 mediated autophagy activation in diabetic intervertebral disc degeneration. Cell Proliferation. 54(2). e12975–e12975. 34 indexed citations
9.
Lin, Jialiang, Jiaoxiang Chen, Zengjie Zhang, et al.. (2019). Luteoloside Inhibits IL-1β-Induced Apoptosis and Catabolism in Nucleus Pulposus Cells and Ameliorates Intervertebral Disk Degeneration. Frontiers in Pharmacology. 10. 40 indexed citations
10.
Wang, Ke, Tingting Chen, Xiaozhou Ying, et al.. (2019). Ligustilide alleviated IL-1β induced apoptosis and extracellular matrix degradation of nucleus pulposus cells and attenuates intervertebral disc degeneration in vivo. International Immunopharmacology. 69. 398–407. 69 indexed citations
12.
Zheng, Xuan-Qi, Jinfeng Huang, Jialiang Lin, et al.. (2019). 3D bioprinting in orthopedics translational research. Journal of Biomaterials Science Polymer Edition. 30(13). 1172–1187. 26 indexed citations
13.
Zhang, Zengjie, Jialiang Lin, Majid Nisar, et al.. (2019). The Sirt1/P53 Axis in Diabetic Intervertebral Disc Degeneration Pathogenesis and Therapeutics. Oxidative Medicine and Cellular Longevity. 2019. 1–21. 37 indexed citations
14.
Wang, Min, Chenggui Wang, Mi Chen, et al.. (2019). Efficient Angiogenesis-Based Diabetic Wound Healing/Skin Reconstruction through Bioactive Antibacterial Adhesive Ultraviolet Shielding Nanodressing with Exosome Release. ACS Nano. 13(9). 10279–10293. 456 indexed citations breakdown →
15.
Zhang, Zengjie, Tianzhen Xu, Jiaoxiang Chen, et al.. (2018). Parkin-mediated mitophagy as a potential therapeutic target for intervertebral disc degeneration. Cell Death and Disease. 9(10). 980–980. 79 indexed citations
16.
Wang, Chenggui, Min Wang, Tianzhen Xu, et al.. (2018). Engineering Bioactive Self-Healing Antibacterial Exosomes Hydrogel for Promoting Chronic Diabetic Wound Healing and Complete Skin Regeneration. Theranostics. 9(1). 65–76. 700 indexed citations breakdown →
17.
Zhang, Zengjie, Jialiang Lin, Naifeng Tian, et al.. (2018). Melatonin protects vertebral endplate chondrocytes against apoptosis and calcification via the Sirt1‐autophagy pathway. Journal of Cellular and Molecular Medicine. 23(1). 177–193. 69 indexed citations
18.
Wang, Chenggui, Zengjie Zhang, Tianzhen Xu, et al.. (2018). Upregulating mTOR/ERK signaling with leonurine for promoting angiogenesis and tissue regeneration in a full-thickness cutaneous wound model. Food & Function. 9(4). 2374–2385. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026